Cardinal Health Return on Tangible Equity 2010-2024 | CAH

Current and historical return on tangible equity values for Cardinal Health (CAH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Cardinal Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $1.31B $-10.36B -13.30%
2024-09-30 $1.28B $-9.66B -13.50%
2024-06-30 $0.85B $-9.66B -9.17%
2024-03-31 $0.62B $-9.77B -6.77%
2023-12-31 $0.71B $-8.82B -7.94%
2023-09-30 $0.21B $-8.92B -2.34%
2023-06-30 $0.33B $-9.04B -3.69%
2023-03-31 $0.46B $-8.79B -5.22%
2022-12-31 $-1.28B $-8.83B 14.59%
2022-09-30 $-1.10B $-9.15B 13.01%
2022-06-30 $-0.94B $-8.34B 11.28%
2022-03-31 $-0.96B $-8.72B 11.50%
2021-12-31 $0.56B $-7.60B -6.75%
2021-09-30 $1.14B $-8.61B -13.19%
2021-06-30 $0.61B $-8.30B -6.87%
2021-03-31 $1.15B $-8.39B -12.53%
2020-12-31 $1.38B $-9.13B -14.34%
2020-09-30 $0.97B $-9.76B -9.75%
2020-06-30 $-3.70B $-9.48B 36.12%
2020-03-31 $-4.16B $-10.17B 45.04%
2019-12-31 $-4.21B $-10.52B 52.03%
2019-09-30 $-4.15B $-10.76B 59.76%
2019-06-30 $1.36B $-5.48B -23.48%
2019-03-31 $0.00B $-5.63B -0.03%
2018-12-31 $-0.04B $-5.93B 0.62%
2018-09-30 $0.73B $-6.18B -11.35%
2018-06-30 $0.26B $-6.17B -3.67%
2018-03-31 $1.70B $-6.76B -28.14%
2017-12-31 $1.82B $-6.75B -36.50%
2017-09-30 $1.09B $-8.23B -27.07%
2017-06-30 $1.29B $-2.38B -47.56%
2017-03-31 $1.35B $-2.62B -47.61%
2016-12-31 $1.35B $-2.94B -48.66%
2016-09-30 $1.35B $-2.90B -51.27%
2016-06-30 $1.43B $-2.86B -65.63%
2016-03-31 $1.39B $-2.42B -99.21%
2015-12-31 $1.37B $-2.39B -192.28%
2015-09-30 $1.33B $-1.04B -2229.29%
2015-06-30 $1.22B $0.24B 429.71%
2015-03-31 $1.15B $0.34B 324.16%
2014-12-31 $1.10B $0.22B 217.86%
2014-09-30 $1.09B $0.33B 154.16%
2014-06-30 $1.17B $0.53B 144.40%
2014-03-31 $0.35B $0.94B 44.77%
2013-12-31 $0.38B $1.03B 58.49%
2013-09-30 $0.40B $0.73B 43.95%
2013-06-30 $0.33B $0.40B 28.00%
2013-03-31 $1.16B $0.42B 74.30%
2012-12-31 $1.14B $2.11B 59.62%
2012-09-30 $1.10B $1.84B 60.91%
2012-06-30 $1.07B $1.85B 62.25%
2012-03-31 $1.04B $1.87B 62.66%
2011-12-31 $0.95B $1.68B 61.87%
2011-09-30 $0.90B $1.47B 64.53%
2011-06-30 $0.96B $1.59B 59.36%
2011-03-31 $0.98B $1.39B 49.60%
2010-12-31 $0.96B $1.14B 39.78%
2010-09-30 $0.98B $2.34B 34.23%
2010-06-30 $0.64B $3.02B 21.90%
2010-03-31 $0.69B $3.10B 18.26%
2009-12-31 $0.78B $2.93B 21.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $30.619B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.539B 20.67
Becton Dickinson (BDX) United States $65.341B 16.36
Straumann Holding AG (SAUHY) Switzerland $23.663B 0.00
Labcorp (LH) United States $20.727B 17.01
Cooper (COO) United States $17.256B 23.37
Align Technology (ALGN) United States $15.064B 28.62
West Pharmaceutical Services (WST) United States $14.641B 30.00
Henry Schein (HSIC) United States $9.704B 18.49
Merit Medical Systems (MMSI) United States $6.202B 31.67
DENTSPLY SIRONA (XRAY) United States $3.773B 10.26
Patterson (PDCO) United States $2.741B 14.64
CONMED (CNMD) United States $1.948B 15.15
STAAR Surgical (STAA) United States $0.876B 0.00
Lifevantage (LFVN) United States $0.230B 25.50
Pro-Dex (PDEX) United States $0.112B 17.13